ARNOLD & PORTER KAYE SCHOLER LLP

ARNOLD & PORTER KAYE SCHOLER LLP filed a registration for SUMITOMO PHARMA AMERICA, INC. on March 23, 2026.

Lobbying for SUMITOMO PHARMA AMERICA, INC. · Manufacturer of oncology, rare disease, CNS, urology, and women's health treatments.

All filings by ARNOLD & PORTER KAYE SCHOLER LLP · Everything SUMITOMO PHARMA AMERICA, INC. has reported

Filing · LD-1 registration Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Mar 23, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 4

SONJA NESBIT New on this filing

Previously held: Deputy Assistant Secretary of Legislation, U.S. Dept. of Health & Human Services (2013-16); Deputy Staff Director, Subcommittee on Income Security and Family Support, House Ways and Means Committee (2002-13)
AISHWARYA GRANDHE New on this filing

Previously held: Intern, Senate Agriculture, Nutrition, and Forestry Committee (2024); Intern, Rep. Bonamici (2022)
BOBBY MCMILLIN New on this filing

Previously held: General Counsel, Senate Health, Education, Labor, & Pensions (HELP) Committee (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)
PETER ERIC DUYSHART New on this filing

Previously held: Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Health Issues

Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.

Medicare/Medicaid

Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

SUMITOMO PHARMA CO., LTD.

Japan · Osaka 541-0045 · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.